RECRO PHARMA INC - COM (SCTL) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2024

Type / Class
Equity / COM
Symbol
SCTL
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of RECRO PHARMA INC - COM (SCTL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$54,624,960 0
2024 Q1 50,577,993 $54,625,238 +$6,694,302 $1.08 44
2023 Q4 54,034,651 $18,938,016 -$1,453,778 $0.35 39
2023 Q3 59,989,847 $28,137,178 +$7,237,504 $0.47 46
2023 Q2 47,406,459 $52,147,168 +$4,408,177 $1.10 41
2023 Q1 43,282,753 $50,146,768 -$5,319,922 $1.19 45
2022 Q4 47,723,194 $71,103,902 +$31,154,220 $1.49 47
2022 Q3 21,104,040 $34,397,517 -$1,286,868 $1.63 44
2022 Q2 24,527,409 $19,493,252 -$4,194,254 $0.79 41
2022 Q1 27,690,915 $49,837,571 -$1,125,857 $1.80 49
2021 Q4 28,335,852 $48,442,542 +$738,192 $1.71 53
2021 Q3 27,481,904 $56,607,117 -$3,551,219 $2.06 57
2021 Q2 31,805,039 $73,460,599 +$21,874,226 $2.31 63
2021 Q1 19,407,984 $54,149,893 +$14,502,980 $2.79 71
2020 Q4 14,205,091 $40,479,753 +$2,242,568 $2.85 65
2020 Q3 13,717,269 $28,803,807 -$7,928,540 $2.10 62
2020 Q2 14,445,396 $65,721,141 -$9,456,333 $4.55 85
2020 Q1 14,410,404 $118,013,691 -$26,320,398 $8.17 93
2019 Q4 15,670,635 $287,121,712 +$37,879,514 $18.33 110
2019 Q3 13,479,224 $149,459,010 +$2,112,877 $11.08 95
2019 Q2 13,351,533 $135,695,831 +$14,476,764 $10.17 80
2019 Q1 12,669,848 $74,244,306 +$2,509,639 $5.86 70
2018 Q4 12,169,310 $86,404,634 +$6,803,412 $7.10 67
2018 Q3 11,210,695 $79,698,781 -$935,004 $7.11 73
2018 Q2 11,574,542 $58,080,328 -$14,543,133 $5.02 77
2018 Q1 11,514,933 $126,783,358 +$6,753,290 $11.01 76
2017 Q4 11,079,397 $102,516,951 -$3,971,679 $9.25 62
2017 Q3 11,768,240 $105,683,058 -$4,606,165 $8.98 62
2017 Q2 12,401,280 $87,176,074 +$1,872,295 $7.03 60
2017 Q1 12,044,500 $105,316,026 -$3,868,192 $8.74 45
2016 Q4 12,649,749 $101,955,635 +$50,345,978 $8.06 48
2016 Q3 6,356,693 $56,191,000 +$18,097,102 $8.84 34
2016 Q2 4,310,073 $34,262,000 +$1,392,179 $7.95 22
2016 Q1 4,135,361 $24,687,000 +$592,935 $5.97 20
2015 Q4 4,028,663 $36,256,000 -$1,025,077 $9.00 19
2015 Q3 4,004,503 $48,170,300 +$17,442,246 $12.02 24
2015 Q2 2,552,504 $32,977,200 +$1,098,035 $12.92 22
2015 Q1 2,511,455 $22,778,000 -$3,826,635 $9.07 14
2014 Q4 3,015,921 $8,643,000 +$2,223,301 $2.86 10
2014 Q3 2,260,126 $6,689,000 -$4,207,586 $2.96 9
2014 Q2 2,227,790 $17,844,000 +$965,026 $8.01 10
2014 Q1 2,117,639 $15,474,000 +$15,474,000 $7.32 6